EP0594357A1 — End of dose indicator
Assigned to Eli Lilly and Co · Expires 1994-04-27 · 32y expired
What this patent protects
This invention provides an improvement in injection syringes by providing for a sound as an indication that the complete dose has been administered. The end of dose indicator (20) of this invention is operatively associated with the dose knob (15) of a injection syringe (1) which…
USPTO Abstract
This invention provides an improvement in injection syringes by providing for a sound as an indication that the complete dose has been administered. The end of dose indicator (20) of this invention is operatively associated with the dose knob (15) of a injection syringe (1) which is raised to set the dose and pushed to inject the dose. The improvement comprises a means for producing a sound which is set to produce a sound when the dose knob (15) is pushed to the end of the dose and also includes a means (24) for resetting the above means when pressure is released from the dose knob (15) after the dose is injected.
Drugs covered by this patent
- Ozempic (semaglutide) · Novo Nordisk
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.